LFMD vs. AUNA, WGS, ZJYL, PACB, ALEC, STTK, ANL, OCS, PROK, and TVTX
Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Auna (AUNA), GeneDx (WGS), Jin Medical International (ZJYL), Pacific Biosciences of California (PACB), Alector (ALEC), Shattuck Labs (STTK), Adlai Nortye (ANL), Oculis (OCS), ProKidney (PROK), and Travere Therapeutics (TVTX). These companies are all part of the "medical" sector.
Auna (NYSE:AUNA) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk.
LifeMD received 22 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 70.27% of users gave LifeMD an outperform vote.
35.5% of LifeMD shares are held by institutional investors. 18.9% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Auna presently has a consensus price target of $14.15, suggesting a potential upside of 59.35%. LifeMD has a consensus price target of $11.60, suggesting a potential upside of 21.72%. Given LifeMD's higher possible upside, equities research analysts plainly believe Auna is more favorable than LifeMD.
Auna has higher earnings, but lower revenue than LifeMD.
Auna has a net margin of 0.00% compared to Auna's net margin of -14.75%.
In the previous week, LifeMD had 11 more articles in the media than Auna. MarketBeat recorded 17 mentions for LifeMD and 6 mentions for Auna. LifeMD's average media sentiment score of 0.18 beat Auna's score of 0.12 indicating that Auna is being referred to more favorably in the media.
Summary
LifeMD beats Auna on 6 of the 11 factors compared between the two stocks.
Get LifeMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
